Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick M Sluss

Showing results (21-30 of 80) with videos related to

Pageof 8
Sort By:
Journal of the American Society of Cytopathology|May 5, 2019
Analysis of VEGF/PlGF heterodimer level in pancreatic cyst fluid as a biomarker for serous cystadenomaRoseann I Wu, Patrick M Sluss, Mari Mino-Kenudson, et al.
American Journal of Epidemiology|February 19, 2005
Genetic variation in the progesterone receptor gene and ovarian cancer riskKathryn L Terry, Immaculata De Vivo, Linda Titus-Ernstoff, et al.
The Journal of Clinical Endocrinology and Metabolism|December 6, 2002
Is the short follicular phase in older women secondary to advanced or accelerated dominant follicle development?Nancy A Klein, Andrew J Harper, Brenda S Houmard, et al.
The Journal of Clinical Endocrinology and Metabolism|October 2, 2013
The impact of depot GnRH agonist on AMH levels in healthy reproductive-aged womenH Irene Su, Kevin Maas, Patrick M Sluss, et al.
Steroids|November 7, 2012
Dynamics of serum testosterone during the menstrual cycle evaluated by daily measurements with an ID-LC-MS/MS method and a 2nd generation automated immunoassayHong N Bui, Patrick M Sluss, Stuart Blincko, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 5, 2010
p53 autoantibodies as potential detection and prognostic biomarkers in serous ovarian cancerKaren S Anderson, Jessica Wong, Allison Vitonis, et al.
Human Reproduction (Oxford, England)|November 20, 2004
Reproductive ageing and ovarian function: is the early follicular phase FSH rise necessary to maintain adequate secretory function in older ovulatory women?Karl R Hansen, Angela C Thyer, Patrick M Sluss, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|April 15, 2019
Estradiol reference intervals in women during the menstrual cycle, postmenopausal women and men using an LC-MS/MS methodSara J E Verdonk, Hubert W Vesper, Frans Martens, et al.
The Journal of Steroid Biochemistry and Molecular Biology|November 24, 2004
Steroidogenic activities in MA-10 Leydig cells are differentially altered by cAMP and Müllerian inhibiting substanceAlexander M Trbovich, Nina Martinelle, Francis H O'Neill, et al.
Cancer Research|June 21, 2013
A 20-year prospective study of plasma prolactin as a risk marker of breast cancer developmentShelley S Tworoger, A Heather Eliassen, Xuehong Zhang, et al.
Pageof 8

Showing results (21-30 of 80) with videos related to

Sort By:
Pageof 8
Journal of the American Society of Cytopathology|May 5, 2019
Analysis of VEGF/PlGF heterodimer level in pancreatic cyst fluid as a biomarker for serous cystadenomaRoseann I Wu, Patrick M Sluss, Mari Mino-Kenudson, et al.
American Journal of Epidemiology|February 19, 2005
Genetic variation in the progesterone receptor gene and ovarian cancer riskKathryn L Terry, Immaculata De Vivo, Linda Titus-Ernstoff, et al.
The Journal of Clinical Endocrinology and Metabolism|December 6, 2002
Is the short follicular phase in older women secondary to advanced or accelerated dominant follicle development?Nancy A Klein, Andrew J Harper, Brenda S Houmard, et al.
The Journal of Clinical Endocrinology and Metabolism|October 2, 2013
The impact of depot GnRH agonist on AMH levels in healthy reproductive-aged womenH Irene Su, Kevin Maas, Patrick M Sluss, et al.
Steroids|November 7, 2012
Dynamics of serum testosterone during the menstrual cycle evaluated by daily measurements with an ID-LC-MS/MS method and a 2nd generation automated immunoassayHong N Bui, Patrick M Sluss, Stuart Blincko, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 5, 2010
p53 autoantibodies as potential detection and prognostic biomarkers in serous ovarian cancerKaren S Anderson, Jessica Wong, Allison Vitonis, et al.
Human Reproduction (Oxford, England)|November 20, 2004
Reproductive ageing and ovarian function: is the early follicular phase FSH rise necessary to maintain adequate secretory function in older ovulatory women?Karl R Hansen, Angela C Thyer, Patrick M Sluss, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|April 15, 2019
Estradiol reference intervals in women during the menstrual cycle, postmenopausal women and men using an LC-MS/MS methodSara J E Verdonk, Hubert W Vesper, Frans Martens, et al.
The Journal of Steroid Biochemistry and Molecular Biology|November 24, 2004
Steroidogenic activities in MA-10 Leydig cells are differentially altered by cAMP and Müllerian inhibiting substanceAlexander M Trbovich, Nina Martinelle, Francis H O'Neill, et al.
Cancer Research|June 21, 2013
A 20-year prospective study of plasma prolactin as a risk marker of breast cancer developmentShelley S Tworoger, A Heather Eliassen, Xuehong Zhang, et al.
Pageof 8